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Abstract. This paper presents results of the structural investigation on the human insulin hexamer deri-
vative stabilised by nickel coordination. Single crystals of the Ni-insulin derivative were prepared by the 
hanging drop vapour diffusion crystallisation method using metal-free insulin and nickel(II) acetate tetra-
hydrate. The low-temperature crystal structure was determined by the single crystal X-ray crystallographic 
method with data extending to 1.35 Å spacing. The investigated insulin derivative exhibits the T6 form of 
insulin and crystallizes in the trigonal system in space group R3, with the unit cell parameters a = b = 
81.41 Å and c = 33.75 Å. There are two nickel atoms per insulin hexamer and both are octahedrally coor-
dinated by three Nε2 atoms of three symmetry-related HisB10/HisD10 and three oxygen atoms of three 
symmetry-related water molecules.  
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INTRODUCTION 
Insulin is a hormone synthesized in humans and other 
mammals within the β-cells of the islets of Langerhans 
in the pancreas. It regulates carbohydrate metabolism 
and is also involved in the metabolism of fat and pro-
teins. Insulin is used to control the level of blood sugar 
in patients with Type 1 diabetes mellitus and occasion-
ally in some patients with Type 2 diabetes mellitus.  
The molecule is structured of two polypeptide 
chains, chain A consisting of 21 and chain B of 30 amino 
acids. Chain A and chain B are linked by two disulphide 
bridges, while the third disulphide bridge links residues 
A6 and A11 by an intra-molecular bond. In the presence 
of zinc ions and some other divalent cations, insulin 
forms hexamers. Although insulin is accumulated in the 
pancreas as a Zn2+ containing hexamer, it is active as a 
monomer that does not contain zinc.1 
The native insulin monomer forms multimers at 
the concentrations necessary for crystal growth; thus the 
crystal structure analysis of the active native monomeric 
molecule is impossible. In the absence of metal ions 
native insulin crystallizes as a dimer. There are three 
forms of insulin hexamers named 6T ,  
f
3 3T R  and 6R .  
These notations refer to the folding of the N-terminal 
part of the B chains in insulin hexamers.2 All of these 
forms of insulin are used in therapeutic preparations for 
the control of diabetes. 
The first crystal structure of insulin was described 
by Adams et al.3 in 1969 and two years later in more 
details by Blundell et al.4 This form of insulin was origi-
nally called 2Zn insulin since two zinc ions are bound 
by the hexamer. In 2Zn insulin both of the zinc ions are 
octahedrally coordinated by three HisB10 ligands and 
three water molecules. Later, when the T/R confor-
mational notation was introduced the 2Zn form was 
called T6 form. The T6 insulin form was also investi-
gated in details at a resolution of 1.0 Å.5 The second 
form of insulin hexamer was originally called 4Zn insu-
lin and according to the T/R conformational notation 
that form is T3R3.
6 In that form, the N-termini of three 
out of the six B chains show a conformational change 
from extended strand to an α-helix. This form of insulin 
crystallizes in the presence of high chloride or thio-
cyanate concentration. It was found that in the T3R3 type 
of hexamer there can be a different number of Zn ions 
per hexamer with different coordination.7–9  
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The third insulin hexamer form is the R6 form, 
which crystallizes in the presence of phenol and phenolic 
derivatives.10 In the R6 form both zinc ions lie on the 
molecule's 3-fold axis and are tetrahedrally coordinated. 
It has been known for many years that different 
metal ions can substitute zinc ions in the 2Zn hexamer, 
however only three such complexes have been structu-
rally characterized. Two are heavy metal derivatives Cd 
and Pb,11 while the third is a Co-derivative, which was 
published recently.12 
Nickel plays numerous biological roles in micro-
organisms and plants. Several nickel-containing en-
zymes are known: ureases, NiFe-hydrogenases, Ni-
tetrapyrrole coenzyme, superoxide dismutase, glyoxo-
lases, aci-reductone dioxygenase, acetyl-CaA decarbonyl-
ase/synthase.13 Also, Ni-specific sensing and transport 
systems have been characterized in numerous micro-
organisms.14 
Nickel is not an essential element in higher organ-
isms. In humans it even presents a health hazard. Con-
tacts with Ni-compounds can cause a variety of adverse 
effects on human health: Ni allergy in the form of con-
tact dermatitis, lung fibrosis, cardiovascular and kidney 
diseases, and cancer of respiratory tract. 
In the present study the Zn2+ ions in insulin were 
substituted with Ni2+. We report here the crystal struc-
ture of the human insulin derivative with nickel in the 
hexamer T6 form. The investigated structure provides 
some details on the metal binding and its coordination 
in the insulin hexamer, and on the conformations of the 




Crystals of the human Ni-insulin derivative were grown 
by the hanging drop vapour diffusion method originally 
established for insulin by Cutfield15 and improved  
by Xiao.16 Biosynthetic human Zn-free insulin was  
supplied by Lilly Research Laboratories. Buffers, salts 
and other reagents were purchased and used without 
further purification. Optimum crystallization conditions 
are as follows: the protein solution consisted of 7.5 mg 
mL–1 of Zn-free insulin in 0.02 mol L–1 HCl, while the 
reservoir solution was at pH = 6.4, containing 1 mmol 
L–1 sodium citrate, volume fraction of aceton φ = 10 %, 
15 mmol L–1 nickel(II) acetate tetrahydrate and redis-
tilled water. Each drop consisted of 1μL of protein solu-
tion and 1μL of reservoir solution. It took about 7 days 
at 291 K for crystals to grow to a suitable size. 
Diffraction Data Collection  
Intensity data for the human nickel insulin derivative 
were collected on a single crystal of dimensions 0.2 × 
0.2 × 0.4 mm3 (Figure 1). The single crystal was cryo-
protected by immersing it in the solution consisting of 
volume fraction φ = 70 % reservoir solution and φ = 30 
% ethylene-glycol. The diffraction data were collected 
at the ELETTRA Synchrotron Light Laboratory, beam-
line XRD-1 (wavelength, λ = 1.00 Å), equipped with a 
CCD detector from MarResearch and a Oxford Cryo-
systems cryocooler. The 1.35 Å data set was collected 
by means of a combination of high- and low-resolution 
sweeps, with oscillation angles of 1.0°. The data were 
processed with MOSFLM17 and then scaled and merged 
Figure 1. Single crystal of T6 human nickel insulin derivative.
Table 1. Data measurement statistics for T6 nickel human 
insulin derivative 
Space group R3 
  
Unit cell parameters  
a = b / Å 81.41 
c / Å 33.75 
α = β / ° 90 
γ / ° 120 
  
Temperature / K 100 
2
iso / ÅB   15.2 
No. of frames 240 
Resolution / Å 16.41–1.35 
Total data 29352 
Unique data 18240 
No. of free reflections 935 
Completeness / % 99.7 
σ( )F F  0.03 
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by use of the CCP4 suite. Data statistics are given in 
Table 1. 
Structure Determination and Refinement  
The protein data bank (PDB) entry 1mso5 from which 
all water molecules, zinc ions and alternate side chains 
were omitted, was taken as a starting model for structure 
refinement. Initially only 4 Å resolution data were in-
cluded in the rigid body refinement and R-factors at that 
point were R = 0.316 and Rfree = 0.342. Refinement was 
carried out using maximum-likelihood minimization 
implemented in REFMAC18 with 5 % of the total data 
being excluded for the purpose of Rfree refinement. The 
structure was then refined at a higher resolution and 
throughout the refinement 2Fo – Fc and Fo – Fc maps 
were calculated and examined by the COOT program.19 
Water molecules were added by the ARP/wARP pro-
gram.20 The final model included 146 water molecules. 
The refinement was carried out using anisotropic dis-
placement parameters of the metal ions (two nickel and 
two sodium ions) and amino acid atoms. Water mole-
cules were refined isotropically, except for those bound 
to Ni. Low electron density was observed for the terminal 
atoms of the side chain of PheD1 so it was given an 
occupancy of 0.5. Some side chains were found to be 
disordered, and alternate conformations were added for 
IleA2, SerA9, GlnB4, ValB12, LeuB17, CysC6, CysC11, 
SerD9 and LysD29. Refinement converged at residual 
of R = 0.126 and Rfree = 0.170. The model has a good 
stereochemistry, the r.m.s. deviations for bond lengths 
and bond angles are 0.028 Å and 2.150°, respectively. 
The geometry of the model was monitored with PRO-
CHECK.21 In the Ramachandran plot 93.0 % of the 
residues are in the most favoured region, 5.8 % in 
additionally allowed regions, and 1.2 % on the border of 
additionally allowed and generously allowed regions 
(SerA9). The refinement statistics are given in Table 2.  
 
RESULTS AND DISCUSSION 
Coordination of Nickel Atoms 
It was already shown that the axial zinc binding cavi-
ties in the insulin hexamer can accommodate different 
metal ions which prefer imidazole and water molecule 
ligands.2,3,5,7–9,11,12 
In the human nickel-insulin derivative the insulin 
molecules are organised in a hexamer very similary to 
that in 2Zn insulin (Figure 2). Both nickel atoms are 
octahedrally coordinated by three Nε2 atoms from three 
symmetry-related His imidazole ligands (HisB10/ 
HisD10) and three oxygen atoms of three symmetry-
related water molecules. The Ni-N bond lengths are 
both 2.06 Å, and Ni-O are 2.15 and 2.18 Å. Bond 
lengths in the 2-Ni insulin are slightly shorter than in the 
Zn-insulin derivative (Zn-N 2.09 and 2.10 Å; Zn-O 2.20 
and 2.23 Å). The two nickel atoms lie 16.58 Å apart on 
the three-fold crystallographic axis. The separation of 
the two metal ions is slightly greater than in the T6  
human Zn-insulin5 and in 2-Co porcine insulin12 (both 
16.42 Å), which also possess octahedrally coordinated 
metal ions. There was no evidence of metal binding to 
Table 2. Data refinement statistics for T6 nickel human insulin 
derivative 
Resolution range / Å 16.93–1.35 
No. of reflections 18240 
R 0.126 
Rfree 0.170 
Cross-validated σA estimated error / Å 0.127 
  
R.m.s. deviations from ideal  
Bond lengths / Å 0.028 
Bond angles / ° 2.150 
Dihedral angles / ° 19.52 
  
Isotropic thermal model restraints / Å2  
Main-chain bonds 2.78 
Main-chain angles 3.90 
Side-chain bonds 5.04 
Side-chain angles 6.72 
 
Figure 2. T6 human nickel insulin derivative viewed down the 
crystallographic three-fold axis. A chains are colored yellow, 
B chains orange, C chains blue and D chains purple. Ni ions 
(green), Na ions (pink) and water molecules (red) bound to 
nickel are presented as spheres. HisB10 and HisD10 are pre-
sented as sticks. 
436 B. Prugovečki et al., Nickel Insulin Derivative 
Croat. Chem. Acta 82 (2009) 433–438 
the GluB13 or GluA17, reported in the structure of the 
insulin derivative with cadmium and lead.11 Py-
MOL22drawings of the nickel coordination sites with 
included electron density (2Fo – Fc) are illustrated in 
Figures 3a and 3b. The second sphere of water mole-
cules that form hydrogen bonds to the ones bound to 
nickel was also modeled. One water molecule lies on 
the three-fold axis and its hydrogen atoms are therefore 
disordered, while the other is farther from the three-fold 
axis and forms hydrogen bonds to the water lying on the 
axis and those coordinating the nickel. The pattern is 
similar around both metal atoms. In contrast, in the Zn-
insulin structure there is a difference in the second 
sphere of water molecules above the two coordination 
sites. In one there are three water molecules residing 
above the three zinc-coordinating waters, while in the 
other there is a continuous electron density above the 
zinc ion and its coordinating waters. This density was 
modelled as disordered water molecules. There is an 
assumption that even a disordered citrate anion might 
occupy that site. 
An analysis of small molecule crystal structures 
containing octahedrally coordinated nickel ion with 
three N-donor ligands and three water molecules was 
carried out by searching the Cambridge Structural  
DataBase23 (CSDB). 21 such structures were found with 
the mean Ni-N and Ni-O bond lengths of 2.080 Å, and 
2.077 Å, respectively. The Protein DataBank24 search 
using the Metalloprotein Database and Browser25 
(MDB) gave 52 structures (resolution ≤ 2.7 Å, R ≤ 0.22) 
with octahedrally coordinated nickel of which 29 had 
histidine as a ligand, and 31 had water bound to the Ni 
ion. The coordination sites in the insulin hexamers are 
therefore well suited for nickel ions.  
For comparison it is interesting to analyze the 
structure of an endopeptidase, astacin from crayfish, 
where zinc was also replaced by nickel in order to probe 
the role of metal for catalysis and structure. The cata-
lytic zinc is coordinated by five ligands: three histidines, 
a tyrosine and a water molecule. Interestingly upon 
replacement with nickel the coordination changes to a 
deformed octahedral since one more water molecules 
enters the coordination sphere. The distances in this 
endopeptidase structure are similar as in the Ni-insulin, 
Ni-N(His) 2.07, 2.09 and 2.18 Å, 2Ni-O(H O)  2.22, 
2.30 Å. Loss of activity was found in the substituted 
enzyme.26 
In insulin the role of the metal ion is only struc-
tural. Since the octahedral coordination is common for 
both Zn and Ni the structural changes upon replacement 
of Zn with Ni are only minor. 
Dimer and Hexamer Conformation 
In the crystal structure of human Ni-insulin derivative 
there are three T6 insulin hexamers in the unit cell, and 
asymmetric unit consists of one T2 dimer. Insulin mole-
cules (monomers) form a hydrogen bonded anti-parallel 
β-sheet in the dimer with hydrogen bond contacts be-
tween insulin momomers at: PheB24···TyrD26 and 
TyrB26···PheD24. In the Ni-insulin derivative the dimer 
is asymmetrical because the B25Phe side chain turns 
away from the two-fold axis and contacts D25Phe 
across the two-fold axis, as in the 2Zn insulin. The Cα 
root mean square difference between the T2 dimer of 
human Ni-insulin derivative and T2 human Zn-insulin
5 
   
a)       b) 
 
Figure 3. Coordination around nickel atoms showing the electron density: a) Ni (green) coordinated by HisB10 and water mole-
cule O1 (red); b) Ni (green) coordinated by HisD10 and water molecule O2 (red). The contacts to ligands are shown by grey
dashed lines. The 2Fo – Fc maps are contoured at 1.4σ. The second sphere of water molecules that form hydrogen bonds to the
ones bound to nickel is also presented. 
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calculated using the CCP4 program LSQKAB27 was 
0.17 Å (Table 3), indicating that the zinc and nickel 
insulin structures are similar within limits of experimen-
tal error. The analogous differences between the Co-
insulin and Zn-insulin structures is 0.39 indicating 
slightly greater difference than for the nickel derivative. 
In the Co-derivative the greatest main chain difference 
was found in the D chain whereas in the Ni-derivative it 
is for the A chain. The side chains which show signifi-
cant differences in conformation in the nickel and zinc 
structures include GlnB4, PheB25, ThrB27 and 
LysD29. This is in agreement with the greatest root 
mean square difference of all atoms in the B chain of 
the Ni-derivative. 
An interesting difference is the disordered di-
sulphide bond between CysC6 and CysC11 which was 
not found in the Zn-derivative. 
The hexamer three identical insulin dimers (re-
lated by the three-fold axis) assemble together around 
the 3-fold axis is stabilized by the metal coordination, 
the burial of non-polar residues along the N-terminus 
and hydrogen bonds between PheB1 and GluC17, 
GlnB4 and LeuD17, GluB21 and AsnD3.  
 
CONCLUSION 
The described structure shows that nickel ion can re-
place the zinc ion in the T6 form of human Zn-insulin. 
The two structures were found to be highly similar with 
differences only in a few side chains. Coordination of 
the metal ion is octahedral in both structures (three His 
and three water molecules). Slightly shorter Ni-N and 
Ni-O bond lenghts were found than the analogous ones 
in the Zn derivative. A difference between the Ni- and 
Zn-insulin structures regarding the second sphere of 
water molecules above the metal coordination site was 
also found.  
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SAŽETAK  
Struktura T6 niklovog derivata ljudskog inzulina pri rezoluciji od 
1,35 Å 
Biserka Prugovečki,a Eleanor J. Dodson,b Guy G. Dodsonb i Dubravka Matković-
Čalogovića 
aLaboratorij za opću i anorgansku kemiju, Kemijski odsjek, Prirodoslovno-matematički fakultet, 
Sveučilište u Zagrebu, Horvatovac 102a, 10 000 Zagreb, Hrvatska 
bYork Structural Biology Laboratory, Department of Chemistry, University of York, Heslington, York 
YO10 5YW England 
U ovom su radu prikazani rezultati strukturnog istraživanja niklovog derivata ljudskog inzulina. Monokristali Ni-
derivata inzulina priređeni su metodom difuzije para u visećoj kapi korištenjem inzulina koji nije sadržavao me-
talne ione i niklovog(II) acetat tetrahidrata. Kristalna struktura navedenog derivata inzulina riješena je metodom 
difrakcije rentgenskog zračenja na monokristalnom uzorku do rezolucije od 1,35 Å. Navedeni inzulinski derivat 
pripada T6 formi heksamera inzulina i kristalizira u trigonskom sustavu u prostornoj grupi R3 s parametrima 
jedinične ćelije a = b = 81,41 Å i c = 33,75 Å. Svaki heksamer inzulina sadrži po dva atoma nikla, oba oktaedarski 
koordinirana s tri atoma Nε2 iz triju simetrijski ovisnih HisB10/ HisD10 i tri kisikova atoma iz triju simetrijski 
ovisnih molekula vode.  
